ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Onconetix, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.43−0.05 (-10.13%)
Close on Oct 19, 2026
- Market cap
- $965.06K
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$815.37KFY2025, +273.4% a year since FY2023